Invesco’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-359,749
| Closed | -$38.6M | – | 3994 |
|
|
2023
Q1 | $38.6M | Buy |
359,749
+76,603
| +27% | +$8.22M | 0.01% | 1061 |
|
|
2022
Q4 | $31.1M | Sell |
283,146
-5,406
| -2% | -$595K | 0.01% | 1138 |
|
|
2022
Q3 | $17M | Buy |
288,552
+273,784
| +1,854% | +$16.2M | 0.01% | 1428 |
|
|
2022
Q2 | $417K | Buy |
14,768
+4,137
| +39% | +$117K | ﹤0.01% | 3400 |
|
|
2022
Q1 | $402K | Sell |
10,631
-51,219
| -83% | -$1.94M | ﹤0.01% | 3471 |
|
|
2021
Q4 | $2.45M | Buy |
+61,850
| New | +$2.45M | ﹤0.01% | 2712 |
|